Remember meForgot password?
    Log in with Twitter

Biotech News

Essential Science: Revolutionizing the CRISPR method

Scientists working at ETH Zurich have refined the CRISPR-Cas gene editing method. Through this it is now possible for researchers to modify dozens of genes within a cell simultaneously, thereby speeding up the process.

South Dakota's emerging biotech ecosystem

Pierre - South Dakota – a state with a population of less than a million people – is anchoring a large biotech ecosystem, focused on tackling global issues with innovations from disease-fighting cows, to light-activated drugs that help repair blood vessels.

Gates launches not-for-profit biotech arm

The Bill & Melinda Gates Foundation have launched a not-for-profit biotechnology company. The Medical Research Institute’s goals are to eradicate malaria, accelerate the end of the tuberculosis epidemic, and end diarrheal deaths in children.

Biotech startup looking for $115 million from the IPO

A new biotech startup from Stanford University called Forty-Seven has announced an initial public offering. This follows on from the presentation of effective data in relation to the company’s monoclonal antibody.

FarmTech: Biotechnology for breeding healthier animals

Edinburgh - By analyzing the genetic code of sheep, researchers have come up with information that will aid breeding programs leading to healthier and more productivity animals. This centers on a review of genes relating to different tissues and organs.

Biotech is advancing the fragrance industry

Biotech has altered the way that perfumes are manufactured, making them more consistent and removing many animal products. New research promises to extend these innovations further.

Novartis forms biotech spin-off called Mereo

Zurich - The pharmaceutical giant Novartis has established a biotech spin-off company called Mereo. The company will be based in the U.K. and it will work on three bespoke investigational drug products.

Biotech company Cellectis floats on stock exchange

Paris - The biotech start-up company Cellectis has gone public for a massive $228 million. This is nearly double the value the company filed for in February 2015.

23andMe to begin drug development

Mountain View - 23andMe, the personal genomics firm, has announced plans to make its own medicines. This will involve deals with biotechnology and pharmaceutical companies.

Biotech companies partner for Parkinson’s research

The biotech companies 23andMe and Genentech are to work together on research into Parkinson’s Disease. The firms have entered a multi-year deal for the analysis of whole-genome sequence data.

Roche invests $3.8 billion in biotech start-up

Bern - The Swiss pharmaceutical giant Roche is set to pay $3.8 billion for InterMune, a Brisbane, California-based biotech with one key product: a treatment for a fatal lung disease.

U.S. campaigners hope to engineer GMO labeling laws

Portland - Two decades after genetically modified foods first hit the shelves of American supermarkets, a fight is sprouting over whether consumers should be told more about what’s in their grocery bags.

French scientists revive assault on pesticide, GM corn

Paris - Scientists who wrote a contested study linking pesticide-treated, genetically-modified corn with tumours and liver and kidney disease in lab rats returned to the attack on Tuesday, republish their work online.

Drug giant Merck buys hepatitis C biotech treatment company

Cambridge - The drug giant Merck is to acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals. Idenix is focused on developing treatments for hepatitis C.

U.S. Department of Defense moves into biotech

Washington - The U.S. Department of Defense has extended its focus on the life sciences by opening a new division of biotechnology, with a focus on improving U.S. defenses.

More firms weigh IPOs as biotech fever reaches Europe

Biotech fever is spreading to Europe from the United States with a successful stock market debut for a cat allergy company in Britain seen as a bellwether that could help unloc...

Trial continues after patient death: French heartmaker

Paris - French biomedical firm Carmat said Tuesday it would implant its experimental artificial heart into another three people, as planned, after the first recipient died.In an email to AFP, the company said it was too soon to draw conclusions about the devic...

Man with first artificial heart dies after 75 days

Paris - A septuagenarian man who was fitted with the French biomedical firm Carmat's first artificial heart two and half months ago has died, a hospital statement said Monday."Seventy-five days after the implant of the first Carmat artificial heart bioprosthes...

Biotech company 'breached animal welfare rules'

Santa Cruz Biotechnology, one of the biggest suppliers of antibodies for laboratory research, is accused of repeatedly violating the Animal Welfare Act according to the USDA.

High tech stem cell company faces challenges

The only U.S. company with an ongoing embryonic stem cell therapy clinical trial is struggling financially and is also facing some legal challenges.

Advance in gene therapy for rare form of blindness

Paris - A groundbreaking experiment to treat a rare form of inherited blindness has notched up startling success in early tests on half a dozen volunteers, doctors reported on Thursday.

Panama to use transgenic mosquitoes in anti-dengue bid

Panama City - Panama will try to control a dengue outbreak that has claimed six lives this year by releasing transgenic mosquitoes to render infertile female transmitters of the disease, officials said.

Gene clue to Latin American risk for diabetes

Paris - Scientists on Wednesday said they had found a variant of a gene to explain why Latin Americans are at higher risk of Type 2 diabetes, and pointed to a possible DNA legacy from the Neanderthals.

First gene therapy in Europe approved

The European Commission has approved a treatment for patients suffering from acute pancreatitis. What is remarkable about this drug approval is that it is the first gene therapy treatment to be approved for use in Europe.

Scientists: Bio-tech spinal implant could ease back pain

Cornell University engineers and doctors announced they have built a bioengineered implant to replace injured or degenerated intervertebral spinal column discs, in a project that has advanced to the animal testing stages, ScienceDaily reported.

Bayer settles with farmers over genetically modified rice seeds

The Bayer CropScience subgroup of the German chemical and pharmaceutical giant Bayer AG agreed to pay U.S. farmers $750 million to settle complaints that strains of the company's bioengineered rice tainted and decreased the export value of their crops.

ExxonMobil will launch biofuels program

ExxonMobil announced an alliance with leading biotech company, Synthetic Genomics Inc. (SGI), to research and develop next generation biofuels from photosynthetic algae.

2006 in Biotech

The top 2006 biotech pushes

Search Digital Journal Archives

Set up a news alert for


Biotech Image

Potato starch
Potato starch
Perfume is being reinvented with the help of biotech
Perfume is being reinvented with the help of biotech
Tomas Barrios (CC BY-SA 2.0)

Latest News
Top News